Rubedo Life Sciences: Funding, Investors & Team (Oct 2026)
Rubedo Life Sciences is a biopharmaceutical company focused on developing a range of innovative therapies designed to target cells responsible for chronic age-related diseases. Through their ALEMBIC drug discovery platform, the company has created unique small molecules that specifically target senescent cells, which play a crucial role in various chronic conditions such as pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. The leadership team at Rubedo consists of industry experts with a wealth of experience in drug development and commercialization, spanning from major pharmaceutical companies to smaller biotech firms.
Rubedo Life Sciences has raised $53.5M across 3 funding rounds on record, the most recent a Series A of $40.0M announced in Apr 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rubedo Life Sciences Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Rubedo Life Sciences Funding Rounds
Rubedo Life Sciences raised $12.0M in an undisclosed round announced in Dec 2020.
2.2 years later, an undisclosed round of $1.5M was announced in Feb 2023.
1.2 years later, a Series A of $40.0M was announced in Apr 2024.
Rubedo Life Sciences Founders and Leadership Team
Contact details for the Rubedo Life Sciences team: 2 of 2 have an email address on file.
Start 14-day free trial →Rubedo Life Sciences Funding Compared to Other Biotechnology Startups
Rubedo Life Sciences' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rubedo Life Sciences in Biotechnology and Sunnyvale
Companies Similar to Rubedo Life Sciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Rubedo Life Sciences Funding FAQs
What does Rubedo Life Sciences do?
Rubedo Life Sciences is a biopharmaceutical company focused on developing a range of innovative therapies designed to target cells responsible for chronic age-related diseases. Through their ALEMBIC drug discovery platform, the company has created unique small molecules that specifically target senescent cells, which play a crucial role in various chronic conditions such as pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. The leadership team at Rubedo consists of industry experts with a wealth of experience in drug development and commercialization, spanning from major pharmaceutical companies to smaller biotech firms.
How much funding has Rubedo Life Sciences raised?
Rubedo Life Sciences has raised $53.5M across 3 rounds on record. The most recent is a Series A of $40.0M announced in Apr 2024.
When did Rubedo Life Sciences last raise funding?
Rubedo Life Sciences' most recent funding round on record is a Series A of $40.0M, announced in Apr 2024.
Who founded Rubedo Life Sciences?
FundedIQ lists Julian Klein (Founder) at Rubedo Life Sciences.
Who is the CEO of Rubedo Life Sciences?
Marco Quarta is listed as CEO at Rubedo Life Sciences.
Where is Rubedo Life Sciences headquartered?
Rubedo Life Sciences is based in Sunnyvale, California, United States.
How many employees does Rubedo Life Sciences have?
Rubedo Life Sciences is in the 11-50 employee band.
How does Rubedo Life Sciences' funding compare to other Biotechnology startups?
Rubedo Life Sciences' latest round of $40.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Rubedo Life Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rubedo Life Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.